India's first patient to undergo indigenous cancer treatment using 'CAR-T cell therapy', a form of immunotherapy that genetically modifies a patient's white blood cells to combat cancer cells, has been declared cancer-free.
The patient, Dr. (Colonel) VK Gupta, a Delhi-based gastroenterologist, took this therapy by paying just INR 4.2 Million which would've otherwise cost him INR 40 Million abroad.
The CAR-T cell therapy, also known as NexCAR19, is a groundbreaking treatment for B-cell cancers like leukaemia and lymphoma.
India's Indigenous Cancer Treatment 'CAR-T Cell Therapy' Cures Its First Patient
© Photo : Twitter/@umedpratapsingh
Developed by ImmunoACT, a company that emerged from the prestigious Indian Institute of Technology Bombay (IITB) and Tata Memorial Hospital, this cutting-edge therapy offers a promising solution to those battling the diseases.
Over 30 hospitals across 10 Indian cities now offer this therapy, providing treatment to eligible patients over 15 years old who are fighting B-cell cancers.